Table 3.

Age and vaccine status of carriers of VT vs. non-VT S. pneumoniae.^‡

	PCV7 Types n (%) n=11	PCV13 Types n (%) n=5	Non-VT n (%) n=63	p-value
Age at enrollment				0.888
0 – 2 years	4 (36.4%)	2 (40.0%)	27 (42.9%)
> 2 years 6 years	6 (54.5%)	3 (60.0%)	25 (39.7%)
> 6 years 12 years	1 (9.1%)	0	9 (14.3%)
> 12 years	0	0	2 (3.2%)
†Vaccine status				0.68
Complete PCV7 series	0	0	4 (6.3%)
Complete PCV13 series	7 (70.0%)	2 (40.0%)	44 (69.8%)
Complete PCV7 and 13 series	2 (20.0%)	2 (40.0%)	9 (14.3%)
Incomplete	1 (10.0%)	1 (20.0%)	6 (9.5%)
Unable to obtain vaccine records	1	0	0

^†Defined complete coverage as having recommended number of doses for age at time of enrollment.

^‡Carriers with isolates that could not be serotyped (n = 5) were excluded from analysis.